BRCA2 and neoplasm: Since blocked replication forks cannot be restarted without the help of PARP1/2, SSB inevitably lead to more severe DSB; hence, tumor cells lacking active BRCA1 or BRCA2 are sensitive to a PARP inhibitor molecule [23].